AMPHAmphastar Pharmaceuticals, Inc.vs its industry peers
A metric-by-metric comparison of Amphastar Pharmaceuticals, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMPHThis | $1.0B#8 | 14.3x#1 | 2.3x#3 | 1.4x#2 | -1.7%#6 | -38.5%#8 | 19.5%#1 | 22.0%#2 | 13.2%#2 | 5#1 | -10.5%#5 | — |
| ANRO | $1.2B#2 | — | 5.4x#10 | — | — | -2.9%#5 | — | -28.8%#6 | — | — | 664.6%#2 | — |
| AKTS | $1.2B#1 | — | 2.5x#6 | — | — | — | — | 0.0%#4 | — | — | 23226.4%#1 | — |
| MNKD | $1.1B#3 | — | — | 3.3x#3 | 22.2%#4 | -78.7%#10 | 11.1%#2 | — | 2283.8%#1 | — | -34.1%#6 | — |
| OBX | $1.1B#4 | — | — | — | — | -21.1%#6 | — | — | — | — | — | — |
| SVRA | $1.1B#5 | — | 7.3x#11 | 4105.2x#8 | — | -23.9%#7 | -48072.8%#8 | -82.7%#11 | -93.6%#6 | — | 41.7%#4 | — |
| JBIO | $1.0B#6 | — | 2.4x#4 | — | — | -83.0%#11 | — | -29.0%#8 | — | — | 129.5%#3 | — |
| MLTX | $1.0B#7 | — | 2.4x#5 | — | — | -91.1%#12 | — | -53.1%#10 | -491.6%#7 | — | -77.2%#7 | — |
| KURA | $1.0B#9 | — | 20.7x#12 | 14.9x#5 | 25.2%#3 | -60.2%#9 | -449.9%#6 | -575.4%#12 | — | — | — | — |
| PCRX | $986M#10 | 70.7x#3 | 1.5x#1 | 1.4x#1 | 3.6%#5 | 107.0%#2 | 2.6%#3 | 1.0%#3 | 1.0%#3 | — | — | — |
| LXRX | $903M#11 | — | 5.2x#9 | 18.1x#6 | 60.2%#2 | 74.9%#3 | -98.2%#5 | -28.8%#7 | -26.4%#5 | — | — | — |
| FTH | $892M#12 | — | 5.2x#8 | — | — | 30.1%#4 | — | -12.2%#5 | -15.2%#4 | — | — | — |
| TBPH | $885M#13 | 16.4x#2 | 3.1x#7 | 8.2x#4 | 66.9%#1 | 287.7%#1 | -3.4%#4 | 36.6%#1 | — | — | — | — |
| WVE | $882M#14 | — | 1.9x#2 | 20.6x#7 | -60.5%#7 | -110.7%#13 | -504.1%#7 | -45.1%#9 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice